Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Recursion Pharmaceuticals ( (RXRX) ) has shared an update.
Ben Taylor, CFO of Recursion Pharmaceuticals, is set to join Exscientia AI Ltd. with a competitive compensation package including a £400,000 salary, bonuses, and a $5 million equity grant. His employment terms ensure financial security through severance and vesting conditions, appealing to investors and financial enthusiasts tracking executive movements in the pharmaceutical sector.
See more data about RXRX stock on TipRanks’ Stock Analysis page.